nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenamide—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.166	0.363	CbGbCtD
Diclofenamide—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.166	0.363	CbGbCtD
Diclofenamide—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.126	0.275	CbGbCtD
Diclofenamide—Metabolic acidosis—Formoterol—chronic obstructive pulmonary disease	0.0205	0.0397	CcSEcCtD
Diclofenamide—Metabolic acidosis—Arformoterol—chronic obstructive pulmonary disease	0.0205	0.0397	CcSEcCtD
Diclofenamide—Metabolic acidosis—Salbutamol—chronic obstructive pulmonary disease	0.0193	0.0375	CcSEcCtD
Diclofenamide—Calculus of kidney—Formoterol—chronic obstructive pulmonary disease	0.0123	0.024	CcSEcCtD
Diclofenamide—Calculus of kidney—Arformoterol—chronic obstructive pulmonary disease	0.0123	0.024	CcSEcCtD
Diclofenamide—Hyperuricaemia—Aminophylline—chronic obstructive pulmonary disease	0.0115	0.0223	CcSEcCtD
Diclofenamide—Blood uric acid increased—Aminophylline—chronic obstructive pulmonary disease	0.0108	0.021	CcSEcCtD
Diclofenamide—Nephrolithiasis—Arformoterol—chronic obstructive pulmonary disease	0.0101	0.0195	CcSEcCtD
Diclofenamide—Nephrolithiasis—Formoterol—chronic obstructive pulmonary disease	0.0101	0.0195	CcSEcCtD
Diclofenamide—Weight decreased—Roflumilast—chronic obstructive pulmonary disease	0.00904	0.0176	CcSEcCtD
Diclofenamide—Disorientation—Aminophylline—chronic obstructive pulmonary disease	0.00862	0.0167	CcSEcCtD
Diclofenamide—Hypokalaemia—Aminophylline—chronic obstructive pulmonary disease	0.00702	0.0136	CcSEcCtD
Diclofenamide—Tension—Roflumilast—chronic obstructive pulmonary disease	0.00683	0.0133	CcSEcCtD
Diclofenamide—Nervousness—Roflumilast—chronic obstructive pulmonary disease	0.00676	0.0131	CcSEcCtD
Diclofenamide—Tremor—Roflumilast—chronic obstructive pulmonary disease	0.00652	0.0127	CcSEcCtD
Diclofenamide—Disorientation—Montelukast—chronic obstructive pulmonary disease	0.00643	0.0125	CcSEcCtD
Diclofenamide—Hypokalaemia—Arformoterol—chronic obstructive pulmonary disease	0.00534	0.0104	CcSEcCtD
Diclofenamide—Hypokalaemia—Formoterol—chronic obstructive pulmonary disease	0.00534	0.0104	CcSEcCtD
Diclofenamide—Ataxia—Salbutamol—chronic obstructive pulmonary disease	0.00521	0.0101	CcSEcCtD
Diclofenamide—Hypokalaemia—Salbutamol—chronic obstructive pulmonary disease	0.00504	0.0098	CcSEcCtD
Diclofenamide—Dyspepsia—Roflumilast—chronic obstructive pulmonary disease	0.005	0.00972	CcSEcCtD
Diclofenamide—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.00494	0.0096	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Roflumilast—chronic obstructive pulmonary disease	0.00491	0.00953	CcSEcCtD
Diclofenamide—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.0049	0.00952	CcSEcCtD
Diclofenamide—Constipation—Roflumilast—chronic obstructive pulmonary disease	0.00486	0.00944	CcSEcCtD
Diclofenamide—Feeling abnormal—Roflumilast—chronic obstructive pulmonary disease	0.00468	0.0091	CcSEcCtD
Diclofenamide—Tension—Aminophylline—chronic obstructive pulmonary disease	0.00456	0.00885	CcSEcCtD
Diclofenamide—Nervousness—Aminophylline—chronic obstructive pulmonary disease	0.00451	0.00876	CcSEcCtD
Diclofenamide—Drowsiness—Montelukast—chronic obstructive pulmonary disease	0.00443	0.00861	CcSEcCtD
Diclofenamide—Tremor—Aminophylline—chronic obstructive pulmonary disease	0.00435	0.00845	CcSEcCtD
Diclofenamide—Drowsiness—Salbutamol—chronic obstructive pulmonary disease	0.00427	0.0083	CcSEcCtD
Diclofenamide—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.00408	0.00792	CcSEcCtD
Diclofenamide—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.00376	0.0073	CcSEcCtD
Diclofenamide—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.00361	0.00702	CcSEcCtD
Diclofenamide—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.00361	0.00702	CcSEcCtD
Diclofenamide—Rash—Roflumilast—chronic obstructive pulmonary disease	0.00358	0.00696	CcSEcCtD
Diclofenamide—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.00357	0.00695	CcSEcCtD
Diclofenamide—Headache—Roflumilast—chronic obstructive pulmonary disease	0.00356	0.00692	CcSEcCtD
Diclofenamide—Tension—Arformoterol—chronic obstructive pulmonary disease	0.00347	0.00674	CcSEcCtD
Diclofenamide—Tension—Formoterol—chronic obstructive pulmonary disease	0.00347	0.00674	CcSEcCtD
Diclofenamide—Nervousness—Formoterol—chronic obstructive pulmonary disease	0.00343	0.00667	CcSEcCtD
Diclofenamide—Nervousness—Arformoterol—chronic obstructive pulmonary disease	0.00343	0.00667	CcSEcCtD
Diclofenamide—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00338	0.00656	CcSEcCtD
Diclofenamide—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.00334	0.00648	CcSEcCtD
Diclofenamide—Tremor—Formoterol—chronic obstructive pulmonary disease	0.00331	0.00643	CcSEcCtD
Diclofenamide—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.00331	0.00643	CcSEcCtD
Diclofenamide—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.00329	0.0064	CcSEcCtD
Diclofenamide—Tension—Salbutamol—chronic obstructive pulmonary disease	0.00327	0.00636	CcSEcCtD
Diclofenamide—Tremor—Montelukast—chronic obstructive pulmonary disease	0.00324	0.0063	CcSEcCtD
Diclofenamide—Nervousness—Salbutamol—chronic obstructive pulmonary disease	0.00324	0.0063	CcSEcCtD
Diclofenamide—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00321	0.00624	CcSEcCtD
Diclofenamide—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00315	0.00611	CcSEcCtD
Diclofenamide—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.00313	0.00608	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00309	0.006	CcSEcCtD
Diclofenamide—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.00306	0.00594	CcSEcCtD
Diclofenamide—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.003	0.00582	CcSEcCtD
Diclofenamide—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00277	0.00538	CcSEcCtD
Diclofenamide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00268	0.00521	CcSEcCtD
Diclofenamide—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.0026	0.00504	CcSEcCtD
Diclofenamide—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00256	0.00498	CcSEcCtD
Diclofenamide—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00256	0.00498	CcSEcCtD
Diclofenamide—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00254	0.00493	CcSEcCtD
Diclofenamide—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00254	0.00493	CcSEcCtD
Diclofenamide—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00254	0.00493	CcSEcCtD
Diclofenamide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00253	0.00491	CcSEcCtD
Diclofenamide—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00251	0.00488	CcSEcCtD
Diclofenamide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00251	0.00487	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00249	0.00484	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00249	0.00484	CcSEcCtD
Diclofenamide—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.00249	0.00483	CcSEcCtD
Diclofenamide—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00249	0.00483	CcSEcCtD
Diclofenamide—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00249	0.00483	CcSEcCtD
Diclofenamide—Constipation—Formoterol—chronic obstructive pulmonary disease	0.00247	0.00479	CcSEcCtD
Diclofenamide—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.00247	0.00479	CcSEcCtD
Diclofenamide—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00245	0.00475	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00244	0.00474	CcSEcCtD
Diclofenamide—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00244	0.00473	CcSEcCtD
Diclofenamide—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00242	0.0047	CcSEcCtD
Diclofenamide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00241	0.00468	CcSEcCtD
Diclofenamide—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.0024	0.00466	CcSEcCtD
Diclofenamide—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00239	0.00464	CcSEcCtD
Diclofenamide—CA7—trachea—chronic obstructive pulmonary disease	0.00238	0.116	CbGeAlD
Diclofenamide—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00238	0.00462	CcSEcCtD
Diclofenamide—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00238	0.00462	CcSEcCtD
Diclofenamide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00237	0.00461	CcSEcCtD
Diclofenamide—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00237	0.0046	CcSEcCtD
Diclofenamide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00236	0.00459	CcSEcCtD
Diclofenamide—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00235	0.00457	CcSEcCtD
Diclofenamide—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00235	0.00456	CcSEcCtD
Diclofenamide—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.00233	0.00453	CcSEcCtD
Diclofenamide—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00228	0.00443	CcSEcCtD
Diclofenamide—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00228	0.00443	CcSEcCtD
Diclofenamide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00227	0.00442	CcSEcCtD
Diclofenamide—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00225	0.00438	CcSEcCtD
Diclofenamide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00225	0.00437	CcSEcCtD
Diclofenamide—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00224	0.00436	CcSEcCtD
Diclofenamide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00224	0.00435	CcSEcCtD
Diclofenamide—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00223	0.00434	CcSEcCtD
Diclofenamide—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00215	0.00418	CcSEcCtD
Diclofenamide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00212	0.00413	CcSEcCtD
Diclofenamide—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.0021	0.00408	CcSEcCtD
Diclofenamide—CA12—respiratory system—chronic obstructive pulmonary disease	0.0021	0.102	CbGeAlD
Diclofenamide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00207	0.00402	CcSEcCtD
Diclofenamide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00207	0.00402	CcSEcCtD
Diclofenamide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00204	0.00397	CcSEcCtD
Diclofenamide—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00204	0.00397	CcSEcCtD
Diclofenamide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00203	0.00394	CcSEcCtD
Diclofenamide—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.002	0.00388	CcSEcCtD
Diclofenamide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00195	0.0038	CcSEcCtD
Diclofenamide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00193	0.00374	CcSEcCtD
Diclofenamide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.00191	0.00371	CcSEcCtD
Diclofenamide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.00191	0.00371	CcSEcCtD
Diclofenamide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.00187	0.00363	CcSEcCtD
Diclofenamide—CA12—connective tissue—chronic obstructive pulmonary disease	0.00184	0.0895	CbGeAlD
Diclofenamide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.00183	0.00356	CcSEcCtD
Diclofenamide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.00183	0.00356	CcSEcCtD
Diclofenamide—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00182	0.00353	CcSEcCtD
Diclofenamide—Rash—Formoterol—chronic obstructive pulmonary disease	0.00182	0.00353	CcSEcCtD
Diclofenamide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00181	0.00351	CcSEcCtD
Diclofenamide—Headache—Formoterol—chronic obstructive pulmonary disease	0.00181	0.00351	CcSEcCtD
Diclofenamide—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.00181	0.00351	CcSEcCtD
Diclofenamide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.0018	0.0035	CcSEcCtD
Diclofenamide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.0018	0.00349	CcSEcCtD
Diclofenamide—Rash—Montelukast—chronic obstructive pulmonary disease	0.00178	0.00346	CcSEcCtD
Diclofenamide—Headache—Montelukast—chronic obstructive pulmonary disease	0.00177	0.00344	CcSEcCtD
Diclofenamide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.00173	0.00336	CcSEcCtD
Diclofenamide—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00172	0.00334	CcSEcCtD
Diclofenamide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.00171	0.00333	CcSEcCtD
Diclofenamide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.00171	0.00333	CcSEcCtD
Diclofenamide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.00171	0.00332	CcSEcCtD
Diclofenamide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.00168	0.00326	CcSEcCtD
Diclofenamide—CA1—respiratory system—chronic obstructive pulmonary disease	0.00166	0.0806	CbGeAlD
Diclofenamide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.00162	0.00314	CcSEcCtD
Diclofenamide—CA12—trachea—chronic obstructive pulmonary disease	0.00155	0.0752	CbGeAlD
Diclofenamide—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.0014	0.00273	CcSEcCtD
Diclofenamide—CA4—respiratory system—chronic obstructive pulmonary disease	0.0013	0.063	CbGeAlD
Diclofenamide—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.00129	0.0025	CcSEcCtD
Diclofenamide—CA12—lung—chronic obstructive pulmonary disease	0.00111	0.054	CbGeAlD
Diclofenamide—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.00108	0.0021	CcSEcCtD
Diclofenamide—CA2—respiratory system—chronic obstructive pulmonary disease	0.00108	0.0522	CbGeAlD
Diclofenamide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00103	0.00201	CcSEcCtD
Diclofenamide—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.00102	0.00198	CcSEcCtD
Diclofenamide—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000999	0.00194	CcSEcCtD
Diclofenamide—CA5B—lung—chronic obstructive pulmonary disease	0.000998	0.0484	CbGeAlD
Diclofenamide—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000987	0.00192	CcSEcCtD
Diclofenamide—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000985	0.00191	CcSEcCtD
Diclofenamide—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000979	0.0019	CcSEcCtD
Diclofenamide—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000979	0.0019	CcSEcCtD
Diclofenamide—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000971	0.00189	CcSEcCtD
Diclofenamide—CA4—trachea—chronic obstructive pulmonary disease	0.000959	0.0465	CbGeAlD
Diclofenamide—CA2—connective tissue—chronic obstructive pulmonary disease	0.000947	0.046	CbGeAlD
Diclofenamide—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000935	0.00182	CcSEcCtD
Diclofenamide—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000928	0.0018	CcSEcCtD
Diclofenamide—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000897	0.00174	CcSEcCtD
Diclofenamide—CA2—bronchus—chronic obstructive pulmonary disease	0.000885	0.043	CbGeAlD
Diclofenamide—CA1—lung—chronic obstructive pulmonary disease	0.000881	0.0428	CbGeAlD
Diclofenamide—CA2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000866	0.042	CbGeAlD
Diclofenamide—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000814	0.00158	CcSEcCtD
Diclofenamide—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000803	0.00156	CcSEcCtD
Diclofenamide—CA2—trachea—chronic obstructive pulmonary disease	0.000795	0.0386	CbGeAlD
Diclofenamide—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000751	0.00146	CcSEcCtD
Diclofenamide—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000722	0.0014	CcSEcCtD
Diclofenamide—Rash—Prednisone—chronic obstructive pulmonary disease	0.000716	0.00139	CcSEcCtD
Diclofenamide—Headache—Prednisone—chronic obstructive pulmonary disease	0.000711	0.00138	CcSEcCtD
Diclofenamide—CA4—lung—chronic obstructive pulmonary disease	0.000689	0.0334	CbGeAlD
Diclofenamide—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000674	0.00131	CcSEcCtD
Diclofenamide—CA2—lung—chronic obstructive pulmonary disease	0.000571	0.0277	CbGeAlD
Diclofenamide—CA1—C-MYB transcription factor network—ELANE—chronic obstructive pulmonary disease	0.000452	0.0641	CbGpPWpGaD
Diclofenamide—CA9—Regulation of gene expression by Hypoxia-inducible Factor—VEGFA—chronic obstructive pulmonary disease	0.000254	0.036	CbGpPWpGaD
Diclofenamide—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A2—chronic obstructive pulmonary disease	0.00021	0.0297	CbGpPWpGaD
Diclofenamide—CYP2C9—Arachidonate Epoxygenase / Epoxide Hydrolase—GSTP1—chronic obstructive pulmonary disease	0.000195	0.0276	CbGpPWpGaD
Diclofenamide—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A2—chronic obstructive pulmonary disease	0.000191	0.027	CbGpPWpGaD
Diclofenamide—CA1—C-MYB transcription factor network—MPO—chronic obstructive pulmonary disease	0.000174	0.0247	CbGpPWpGaD
Diclofenamide—CYP2C9—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—chronic obstructive pulmonary disease	0.000152	0.0216	CbGpPWpGaD
Diclofenamide—CYP2C9—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—chronic obstructive pulmonary disease	0.000139	0.0196	CbGpPWpGaD
Diclofenamide—CA9—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.000125	0.0177	CbGpPWpGaD
Diclofenamide—CA9—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000118	0.0167	CbGpPWpGaD
Diclofenamide—CA9—Cellular response to hypoxia—VEGFA—chronic obstructive pulmonary disease	0.000112	0.0159	CbGpPWpGaD
Diclofenamide—CA1—C-MYB transcription factor network—GSTM1—chronic obstructive pulmonary disease	0.000109	0.0155	CbGpPWpGaD
Diclofenamide—CYP2C9—Xenobiotics—CYP1A2—chronic obstructive pulmonary disease	0.000101	0.0143	CbGpPWpGaD
Diclofenamide—CYP2C9—Tamoxifen metabolism—CYP1A2—chronic obstructive pulmonary disease	9.69e-05	0.0137	CbGpPWpGaD
Diclofenamide—CA9—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	9.57e-05	0.0136	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—SOD3—chronic obstructive pulmonary disease	9.14e-05	0.0129	CbGpPWpGaD
Diclofenamide—CA9—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	8.92e-05	0.0126	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—APIP—chronic obstructive pulmonary disease	7.59e-05	0.0108	CbGpPWpGaD
Diclofenamide—CA9—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	7.51e-05	0.0106	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—APIP—chronic obstructive pulmonary disease	7.4e-05	0.0105	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—APIP—chronic obstructive pulmonary disease	7.4e-05	0.0105	CbGpPWpGaD
Diclofenamide—CYP2C9—Xenobiotics—CYP1A1—chronic obstructive pulmonary disease	7.32e-05	0.0104	CbGpPWpGaD
Diclofenamide—CYP2C9—Tamoxifen metabolism—CYP1A1—chronic obstructive pulmonary disease	7.04e-05	0.00997	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—APIP—chronic obstructive pulmonary disease	6.91e-05	0.00978	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—APIP—chronic obstructive pulmonary disease	6.91e-05	0.00978	CbGpPWpGaD
Diclofenamide—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—chronic obstructive pulmonary disease	6.59e-05	0.00933	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—APIP—chronic obstructive pulmonary disease	6.4e-05	0.00906	CbGpPWpGaD
Diclofenamide—CA9—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	5.17e-05	0.00732	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—APIP—chronic obstructive pulmonary disease	5.1e-05	0.00723	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	5.03e-05	0.00712	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.9e-05	0.00694	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.9e-05	0.00694	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—GC—chronic obstructive pulmonary disease	4.89e-05	0.00693	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—APIP—chronic obstructive pulmonary disease	4.89e-05	0.00693	CbGpPWpGaD
Diclofenamide—CYP2C9—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	4.84e-05	0.00685	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—GC—chronic obstructive pulmonary disease	4.77e-05	0.00675	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—GC—chronic obstructive pulmonary disease	4.77e-05	0.00675	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—APIP—chronic obstructive pulmonary disease	4.69e-05	0.00664	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.58e-05	0.00648	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.58e-05	0.00648	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.55e-05	0.00644	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—GC—chronic obstructive pulmonary disease	4.45e-05	0.0063	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—GC—chronic obstructive pulmonary disease	4.45e-05	0.0063	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.43e-05	0.00628	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.43e-05	0.00628	CbGpPWpGaD
Diclofenamide—CYP2C9—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	4.28e-05	0.00606	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	4.24e-05	0.006	CbGpPWpGaD
Diclofenamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	4.18e-05	0.00592	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—GSTP1—chronic obstructive pulmonary disease	4.18e-05	0.00592	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.14e-05	0.00586	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	4.14e-05	0.00586	CbGpPWpGaD
Diclofenamide—CYP2C9—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	4.13e-05	0.00585	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—GC—chronic obstructive pulmonary disease	4.12e-05	0.00584	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—APIP—chronic obstructive pulmonary disease	4.12e-05	0.00584	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.83e-05	0.00543	CbGpPWpGaD
Diclofenamide—CYP2C9—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	3.52e-05	0.00498	CbGpPWpGaD
Diclofenamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	3.39e-05	0.0048	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.38e-05	0.00479	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—GC—chronic obstructive pulmonary disease	3.29e-05	0.00466	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.24e-05	0.00459	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—GC—chronic obstructive pulmonary disease	3.15e-05	0.00447	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	3.11e-05	0.0044	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	3.06e-05	0.00433	CbGpPWpGaD
Diclofenamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	3.04e-05	0.0043	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—GC—chronic obstructive pulmonary disease	3.02e-05	0.00428	CbGpPWpGaD
Diclofenamide—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	3e-05	0.00425	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.93e-05	0.00415	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.81e-05	0.00398	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.73e-05	0.00387	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.67e-05	0.00379	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—GC—chronic obstructive pulmonary disease	2.66e-05	0.00376	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—GCLC—chronic obstructive pulmonary disease	2.64e-05	0.00374	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.61e-05	0.00369	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.61e-05	0.00369	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—GCLC—chronic obstructive pulmonary disease	2.57e-05	0.00365	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—GCLC—chronic obstructive pulmonary disease	2.57e-05	0.00365	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.47e-05	0.0035	CbGpPWpGaD
Diclofenamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	2.46e-05	0.00349	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.43e-05	0.00344	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.43e-05	0.00344	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—CTGF—chronic obstructive pulmonary disease	2.41e-05	0.00341	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—GCLC—chronic obstructive pulmonary disease	2.4e-05	0.0034	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—GCLC—chronic obstructive pulmonary disease	2.4e-05	0.0034	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—CTGF—chronic obstructive pulmonary disease	2.35e-05	0.00333	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—CTGF—chronic obstructive pulmonary disease	2.35e-05	0.00333	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.25e-05	0.00319	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—GCLC—chronic obstructive pulmonary disease	2.23e-05	0.00315	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.22e-05	0.00315	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—CTGF—chronic obstructive pulmonary disease	2.19e-05	0.00311	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—CTGF—chronic obstructive pulmonary disease	2.19e-05	0.00311	CbGpPWpGaD
Diclofenamide—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	2.17e-05	0.00307	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.16e-05	0.00307	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.16e-05	0.00307	CbGpPWpGaD
Diclofenamide—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	2.14e-05	0.00303	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—CXCL8—chronic obstructive pulmonary disease	2.1e-05	0.00297	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—CTGF—chronic obstructive pulmonary disease	2.03e-05	0.00288	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.02e-05	0.00286	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.02e-05	0.00286	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.87e-05	0.00265	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.85e-05	0.00262	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.83e-05	0.00259	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.81e-05	0.00256	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.81e-05	0.00256	CbGpPWpGaD
Diclofenamide—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	1.8e-05	0.00255	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.8e-05	0.00254	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.78e-05	0.00252	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.78e-05	0.00252	CbGpPWpGaD
Diclofenamide—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	1.78e-05	0.00252	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—GCLC—chronic obstructive pulmonary disease	1.78e-05	0.00252	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.72e-05	0.00244	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—VEGFA—chronic obstructive pulmonary disease	1.7e-05	0.00241	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.7e-05	0.00241	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.7e-05	0.00241	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.69e-05	0.00239	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.69e-05	0.00239	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.66e-05	0.00235	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.66e-05	0.00235	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.66e-05	0.00235	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.66e-05	0.00235	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.65e-05	0.00234	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.63e-05	0.00231	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—CTGF—chronic obstructive pulmonary disease	1.62e-05	0.0023	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.61e-05	0.00229	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.57e-05	0.00223	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.57e-05	0.00223	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.56e-05	0.00221	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.55e-05	0.0022	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.55e-05	0.00219	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.55e-05	0.00219	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.54e-05	0.00218	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	1.52e-05	0.00216	CbGpPWpGaD
Diclofenamide—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.5e-05	0.00213	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.49e-05	0.00211	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.49e-05	0.00211	CbGpPWpGaD
Diclofenamide—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.48e-05	0.0021	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.47e-05	0.00208	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.47e-05	0.00208	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.45e-05	0.00206	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.44e-05	0.00203	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—GCLC—chronic obstructive pulmonary disease	1.44e-05	0.00203	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.43e-05	0.00203	CbGpPWpGaD
Diclofenamide—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.38e-05	0.00195	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.37e-05	0.00194	CbGpPWpGaD
Diclofenamide—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.36e-05	0.00193	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.36e-05	0.00193	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—CTGF—chronic obstructive pulmonary disease	1.31e-05	0.00185	CbGpPWpGaD
Diclofenamide—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.31e-05	0.00185	CbGpPWpGaD
Diclofenamide—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.29e-05	0.00183	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—TP53—chronic obstructive pulmonary disease	1.29e-05	0.00182	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.25e-05	0.00176	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.23e-05	0.00174	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.21e-05	0.00171	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.19e-05	0.00169	CbGpPWpGaD
Diclofenamide—CA9—Cellular responses to stress—IL6—chronic obstructive pulmonary disease	1.18e-05	0.00167	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.18e-05	0.00167	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.14e-05	0.00162	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.14e-05	0.00162	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.13e-05	0.0016	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—ALB—chronic obstructive pulmonary disease	1.1e-05	0.00155	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.1e-05	0.00155	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.08e-05	0.00154	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—ALB—chronic obstructive pulmonary disease	1.07e-05	0.00151	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—ALB—chronic obstructive pulmonary disease	1.07e-05	0.00151	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	1.05e-05	0.00149	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.05e-05	0.00149	CbGpPWpGaD
Diclofenamide—CA14—Metabolism—NOS3—chronic obstructive pulmonary disease	1.05e-05	0.00149	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.04e-05	0.00147	CbGpPWpGaD
Diclofenamide—CA6—Metabolism—NOS3—chronic obstructive pulmonary disease	1.02e-05	0.00145	CbGpPWpGaD
Diclofenamide—CA5A—Metabolism—NOS3—chronic obstructive pulmonary disease	1.02e-05	0.00145	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.01e-05	0.00143	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—ALB—chronic obstructive pulmonary disease	9.98e-06	0.00141	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—ALB—chronic obstructive pulmonary disease	9.98e-06	0.00141	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.97e-06	0.00141	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.92e-06	0.00141	CbGpPWpGaD
Diclofenamide—CA5B—Metabolism—NOS3—chronic obstructive pulmonary disease	9.55e-06	0.00135	CbGpPWpGaD
Diclofenamide—CA7—Metabolism—NOS3—chronic obstructive pulmonary disease	9.55e-06	0.00135	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.25e-06	0.00131	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—ALB—chronic obstructive pulmonary disease	9.25e-06	0.00131	CbGpPWpGaD
Diclofenamide—CA12—Metabolism—NOS3—chronic obstructive pulmonary disease	8.85e-06	0.00125	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.77e-06	0.00124	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	7.51e-06	0.00106	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—ALB—chronic obstructive pulmonary disease	7.37e-06	0.00104	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—ALB—chronic obstructive pulmonary disease	7.07e-06	0.001	CbGpPWpGaD
Diclofenamide—CA4—Metabolism—NOS3—chronic obstructive pulmonary disease	7.05e-06	0.000999	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.97e-06	0.000988	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	6.92e-06	0.000979	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	6.78e-06	0.000961	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—ALB—chronic obstructive pulmonary disease	6.78e-06	0.00096	CbGpPWpGaD
Diclofenamide—CA2—Metabolism—NOS3—chronic obstructive pulmonary disease	6.76e-06	0.000958	CbGpPWpGaD
Diclofenamide—CA1—Metabolism—NOS3—chronic obstructive pulmonary disease	6.48e-06	0.000918	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.31e-06	0.000893	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—ALB—chronic obstructive pulmonary disease	5.96e-06	0.000844	CbGpPWpGaD
Diclofenamide—CA9—Metabolism—NOS3—chronic obstructive pulmonary disease	5.7e-06	0.000807	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	5.02e-06	0.000712	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.71e-06	0.000525	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	3.66e-06	0.000519	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.42e-06	0.000484	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	3.34e-06	0.000473	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.08e-06	0.000436	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.57e-06	0.000364	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.53e-06	0.000359	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.36e-06	0.000334	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.24e-06	0.000317	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	1.52e-06	0.000215	CbGpPWpGaD
Diclofenamide—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	1.46e-06	0.000206	CbGpPWpGaD
